Yahoo!7 News |
FDA issues generic guidance on GSK's top-selling asthma drug, Advair
Philly.com (blog) PhillyPharma. FDA issues generic guidance on GSK's top-selling asthma drug, Advair. GlaxoSmithKline's top-selling drug by far is the asthma medication Advair, which accounts for about 20 percent of company revenue. Generic competition got a bit closer … GlaxoSmithKline Shares Fall After Advair Setback Glaxo Declines as FDA Clears Path for Advair Rivals New FDA guidance threatens GlaxoSmithKline's Advair |
View full post on asthma – Google News